Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
Clinical trial NCT03021187 · COMPLETED
Trial details
- NCT number
- NCT03021187
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-02
- Primary completion
- 2018-01-18
- Enrollment
- 731
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.